VIATRIS INC. Proceeds from Sale of Securities, Operating Activities
VIATRIS INC. (VTRS) reported Proceeds from Sale of Securities, Operating Activities of $45.00 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities · last filed 2024-02-28
- VIATRIS INC. proceeds from sale of securities, operating activities for the quarter ending 2023-09-30 was $45.00M, a 0.00% change year-over-year.
- VIATRIS INC. proceeds from sale of securities, operating activities for the quarter ending 2023-06-30 was $45.00M, a 0.00% change year-over-year.
- VIATRIS INC. proceeds from sale of securities, operating activities for the quarter ending 2023-03-31 was $45.00M, a 0.00% change year-over-year.
- VIATRIS INC. proceeds from sale of securities, operating activities for the quarter ending 2022-09-30 was $45.00M, a 0.00% change year-over-year.
| Period end | Proceeds from Sale of Securities, Operating Activities 3 month | Proceeds from Sale of Securities, Operating Activities 6 month | Proceeds from Sale of Securities, Operating Activities 9 month |
|---|---|---|---|
| 2023-09-30 | $45.00M 10-Q · filed 2023-11-08 | $90.00M derived: sum of 2 quarters · filed 2023-11-08 | $135.00M derived: sum of 3 quarters · filed 2023-11-08 |
| 2023-06-30 | $45.00M 10-Q · filed 2023-08-07 | $90.00M derived: sum of 2 quarters · filed 2023-08-07 | |
| 2023-03-31 | $45.00M 10-Q · filed 2023-05-08 | ||
| 2022-09-30 | $45.00M 10-Q · filed 2022-11-07 | $90.00M derived: sum of 2 quarters · filed 2022-11-07 | $135.00M derived: sum of 3 quarters · filed 2022-11-07 |
| 2022-06-30 | $45.00M 10-Q · filed 2022-08-08 | $90.00M derived: sum of 2 quarters · filed 2022-08-08 | |
| 2022-03-31 | $45.00M 10-Q · filed 2022-05-09 | ||
| 2021-09-30 | $45.00M 10-Q · filed 2021-11-08 | $90.00M derived: sum of 2 quarters · filed 2021-11-08 | $135.00M derived: sum of 3 quarters · filed 2024-02-28 |
| 2021-06-30 | $45.00M 10-Q · filed 2021-08-09 | $90.00M derived: sum of 2 quarters · filed 2024-02-28 | |
| 2021-03-31 | $45.00M 10-K · filed 2024-02-28 | ||
| 2020-03-31 | $45.00M 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |